APA

Assayag F., Brousse N., Couturier J., Macintyre E., Mathiot C., Dewulf S., Froget B., Vincent-Salomon A. & Decaudin D. (20090625). Experimental treatment of human diffuse large B-cell lymphoma xenografts by doxycycline alone or in combination with the anti-CD20 chimeric monoclonal antibody rituximab. : American journal of hematology.

Chicago

Assayag Franck, Brousse Nicole, Couturier Jérôme, Macintyre Elizabeth, Mathiot Claire, Dewulf Sébastien, Froget Benoît, Vincent-Salomon Anne and Decaudin Didier. 20090625. Experimental treatment of human diffuse large B-cell lymphoma xenografts by doxycycline alone or in combination with the anti-CD20 chimeric monoclonal antibody rituximab. : American journal of hematology.

Harvard

Assayag F., Brousse N., Couturier J., Macintyre E., Mathiot C., Dewulf S., Froget B., Vincent-Salomon A. and Decaudin D. (20090625). Experimental treatment of human diffuse large B-cell lymphoma xenografts by doxycycline alone or in combination with the anti-CD20 chimeric monoclonal antibody rituximab. : American journal of hematology.

MLA

Assayag Franck, Brousse Nicole, Couturier Jérôme, Macintyre Elizabeth, Mathiot Claire, Dewulf Sébastien, Froget Benoît, Vincent-Salomon Anne and Decaudin Didier. Experimental treatment of human diffuse large B-cell lymphoma xenografts by doxycycline alone or in combination with the anti-CD20 chimeric monoclonal antibody rituximab. : American journal of hematology. 20090625.